This is supported by the observation that decreased levels of TFPI-2 associate with increased tumour invasion and metastasis in a number of cancers, particularly more aggressive cancers such as glioma (42) and pancreatic cancer (42,43). This evidence concerns the gene TFPI2 and familial pancreatic carcinoma.